CDC Shuts Down Key Labs for Hepatitis and STI Testing After Layoffs

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 21, 2025.

By I. Edwards HealthDay Reporter

MONDAY, April 21, 2025 — Key labs at the U.S. Centers for Disease Control and Prevention (CDC) have shut down amid recent layoffs, raising concerns about tracking and controlling serious infections like viral hepatitis and antibiotic-resistant gonorrhea.

Among those let go were all 27 scientists in the nation’s only lab that performs advanced genetic testing needed for hepatitis outbreaks. That lab had been investigating an outbreak affecting multiple states when the layoffs hit.

“In essence, we’re flying blind,” Scott Becker, head of the Association of Public Health Laboratories, told The Washington Post.

The association wrote a letter to U.S. Health Secretary Robert F. Kennedy Jr. asking for the laid off employees to be reinstated.

“Their loss eliminated critical national testing services that do not exist anywhere else within the [Health and Human Services] agencies,” the letter stated.

The same round of layoffs also shut down a CDC lab that tracked antibiotic-resistant gonorrhea, often called "super gonorrhea." In all, 2,400 CDC employees were let go, The Post reported.

CDC labs have played a key role in tracking outbreaks of hepatitis C, a viral disease that can cause serious liver damage. Outbreaks in recent years have been tied to dialysis facilities, outpatient surgery clinics and prisons.

The CDC had recently identified nine infected patients in Florida tied to one outbreak. The lab was using advanced technology to see if others carried the same virus strain — a process that helps experts understand how diseases are spreading.

The increase in hepatitis C infections has been “stupendous in the past 20 to 25 years,” Dr. Judith Feinberg, a professor of medicine and infectious diseases at West Virginia University, told The Post.

“The CDC lab was capable of showing the genetic linkage between isolates of virus … and that helps you control it from public health policy. It helps you understand how and where disease is spreading, how the virus is evolving,” Feinberg added.

In the U.S., tens of thousands of people get viral hepatitis each year. It can spread through contaminated food, shared needles or close contact with blood that's been infected.

According to the CDC, hepatitis is a leading cause of liver cancer and kills thousands of Americans annually.

The CDC also fired all 28 scientists in its Sexually Transmitted Infections (STI) lab, which tracked infections like chlamydia, syphilis and gonorrhea. That lab was the only one in the U.S. that tested how well antibiotics were working against drug-resistant gonorrhea strains.

“They are one of three laboratories in the world and the only in the U.S. that performs extensive antimicrobial susceptibility testing for gonorrhea,” said Kelly Wroblewski, director of infectious-disease programs at the Association of Public Health Laboratories.

More than 2 million STIs were diagnosed in 2023, including more than 600,000 cases of gonorrhea. Infection rates for gonorrhea, chlamydia and syphilis have jumped 90% in the past 20 years, data show.

Without the lab, Colleen Kelley, a professor of medicine at Emory University who treats patients with HIV and sexually transmitted infections, said, “no one will tell us if we are seeing more cases of this, and no one will be there to sound the alarm bells.”

Sources

  • The Washington Post, April 18, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-22 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords